Tablet for oral suspension

A tablet for oral suspension, comprising:

• carglumic acid in an amount of about 200 mg;
• a diluent comprising microcrystalline cellulose, mannitol, or a combination thereof in an amount of from 228 mg to 280 mg;
• a suspending agent comprising a povidone having a weight average molecular weight of from 44 kDa to 54 kDa in an amount of from 4.4 mg to about 5.4 mg;
• a disintegrant comprising sodium croscarmellose in an amount of from 17 mg to 21 mg;
• a wetting agent comprising sodium stearyl fumarate, magnesium stearate, sodium lauryl sulfate, or a combination thereof in an amount of from 6.35 mg to 7.65 mg;
• and
• a glidant comprising colloidal silicon dioxide in an amount of from 2.3 mg to 2.8 mg;
• wherein the tablet does not include tromethamine or an effervescent agent.